|
There are as many as 18 drugs which are going
out of patent by 2008. The following table connotes India''s capability to manufacture
patented products as soon as these drugs are off-patent.
|
Chemical entity |
Patent expiry date |
Indian manufacturer |
Therapeutic group |
Ceftazidime |
May 1999 |
Orchid Chemicals |
Cephalosporins |
Ceftriaxone |
May 1999 |
Orchid Chemicals |
Cephalosporins |
Felodipine |
June 1999 |
Cipla |
Myocardial
therapy |
Vecuronium
bromide |
August 1999 |
None |
Oxytocics |
Lovastatin |
November 1999 |
None |
Anti-hyperlipidemic |
Enalapril
Maleate |
December 1999 |
Dr Reddy''s Labs,
Hetero Drugs,
Cadila Healthcare, Cipla,
Siris |
Anti-hypertensive |
Lisinopril |
December 1999 |
None |
Anti-hypertensive |
Famotidine |
December 1999 |
Cheminor Drugs,
Manav Pharma, Shree Chemicals Ltd,
Sun Pharmaceuticals,
Ranbaxy Laboratories |
Anti-peptic
Anti-ulcerant |
Roxithromycin |
January 2001 |
Kopran,
Alembic Chemicals |
Macrolide |
Fluoxetine |
February 2001 |
Sun Pharmaceuticals,
Natco Laboratories |
Anti-depressant |
Roxatidine |
June 2001 |
None |
Anti-peptic
Anti-ulcerant |
Ciprofloxacin |
August 2001 |
Dr Reddy''s Labs,
Manav Pharma,
Micro Labs,
Karnataka Antibiotics,
Cadila Healthcare,
Cipla,
Ranbaxy Laboratories,
Kopran,
Natco Laboratories,
Neuland Laboratories,
Siris,
SOL Pharmaceuticals,
Sumitra Pharma,
Torrent |
Quinolones |
Ofloxacin |
August 2001 |
Ranbaxy Laboratories,
Dr Reddy''s Lab |
Quinolones |
Perindopril |
September 2001 |
None |
Anti-hypertensive |
Ondansetron |
September 2001 |
Cipla,
Dr Reddy''s Labs,
Natco |
Anti-emetic |
Floconazole |
October 2003 |
Natco |
Anti-fungal |
Lansoprazole |
December 2003 |
Dr Reddy''s Lab,
Natco Laboratories,
Cipla |
Anti-ulcerant |
Sumatriptan |
August
2008 |
Dr Reddy''s Lab,
Natco Pharma |
Anti-migraine |
also see : Report on contract
manufacturing
|
|
